- Lobbying
- advanced AND life AND sciences
Lobbying Arrangements Results for 'Advanced Life Sciences'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details FDA regulatory pathway for new antibiotic medicines. Biomedical Advanced Research and Development Authority (BARDA) - development of therapeutic counter-measurers of bioterrorism. |
ADVANCED LIFE SCIENCES
|
POLICY DIRECTIONS INC. | |||
Details Federal policies impacting antibiotics and other pharmaceuticals |
Advanced Life Sciences, Inc.
|
MCKENNA, LONG & ALDRIDGE | |||
Details Advanced molecular diagnostic policy. Laboratory and pathology coverage and payment issues. |
Caris Life Sciences, Inc.
|
THE MCMANUS GROUP | |||
Details Medicare Advantage payment rates and policies; CY 2018 Advanced Notice. |
Clover Health, LLC
|
Galileo Consulting Group, Inc. | |||
Details Issues related to the 21st Century Cures Initiative Issues related to FDA reform |
Black Beret Life Sciences, LLC (formerly reporting as Bosarge Life Sciences)
|
BOCKORNY GROUP, INC. | |||
Details Discussion with DoD Officials regarding company therapeutic's applicability to TBI and possible trials. |
Edison Pharmaceuticals
Drug development for treatment of rare mitochondrial disease, TBI, and TON |
Fabiani & Company | |||
Details Advocating for appropriations to address advanced manufacturing and supply chain issues. Advocating for appropriations to address advanced manufacturing and supply chain issues |
United States Pharmacopeial Convention
Pharmaceutical Manufacturing Quality Control Company |
The Conafay Group, LLC | |||
Details Drafted and sent letter to offices of Senators Feinstein and Boxer concerning the need for Congress to include fundedd Energy Title in the Farm Bill reauthorization |
Codexis, Inc.
|
in-house lobbying | |||
Details Lobbied on the importance of PBM transparency, oversight and reform on bills including S. 1339, the Pharmacy Benefit Manager Reform Act (on PBM issues overall and the inclusion of certain reporting... |
California Life Sciences
|
HAGGERTY POLICY SOLUTIONS | |||
Details Issues regarding FDA BARDA (Biomedical Advanced Research and Development Authority) approvals. Indian Health Services (IHS) appropriations. Issues related to Defense Health Agency in the FY24 Nati... |
KNOW Bio, LLC
|
Capitol Counsel, LLC | |||
Details HR 2407/S 2085 The Medicare Multi-Cancer Early Detection Screening Coverage Act; PAMA lab reporting delay included in HR 6363 Further Continuing Appropriations and other Extensions Act Ensuring acc... |
Caris Science Inc
|
SPLITOAK STRATEGIES LLC | |||
Details IRA implementation, transparency, vaccines, coverage and access IRA implementation, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, dru... |
Sanofi US Services, Inc. (formerly known as Genzyme Corporation)
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details FinTech Issues. Workforce, AI, Automation, Autonomous Vehicles, Innovation, Privacy/Data, Life Sciences, Energy Tax Credits. Autonomous Vehicles, Passengerless Autonomous Vehicle Standards, NHTSA R... |
SB GROUP US, INC. DBA SOFTBANK GROUP US, INC.
|
in-house lobbying | |||
Details COMMUNITY DEVELOPMENT PROJECTS Wayne State Center for Healthy Urban Waters Research, Education and Training Appropriations: DoE, DoD, Labor, HHS, Education, HRSA, NIST, Commerce, HUD Summary: ... |
Wayne State University, Detroit, Michigan
|
in-house lobbying |